8% FIXED PROMISSORY NOTE8% Fixed Promissory Note • December 14th, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 14th, 2021 Company Industry JurisdictionThis Amendment No. 3 to 8% Fixed Promissory Note (this “Amendment”), effective as of December 1, 2021 (the “Effective Date”), is made by and among RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”) and White Lion Capital LLC, a Nevada limited liability company (the “Investor”).